Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]European Organisation for Research and Treatment of Cancer"
Count: 402
Selected: 0
NCT IDTitle
NCT02218801A Prospective Colorectal Liver Metastasis Database With an Integrated Quality Assurance Program
NCT02781935Diffusion-Weighted MRI for Liver Metastasis
NCT03134118Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM)
NCT01880359AF CRT +/- Nimorazole in HNSCC
NCT01979393IRCI Gynae Sarcomas, High Grade Uterine Sarcoma
NCT03763422Trial in Low Grade Glioma Patients: Wait or Treat
NCT00626990Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
NCT03345095A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma
NCT02214134SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access
NCT02194842Phase III Radium 223 mCRPC-PEACE III
NCT04031677Surgery With Our Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
NCT03609047Adjuvant Palbociclib in Elderly Patients With Breast Cancer
NCT01101425Male Breast Cancer: Understanding the Biology for Improved Patient Care
NCT02972060ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancer
NCT04790253PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)
NCT04128072Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma
NCT04127110Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients
NCT02834884SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
NCT02436733Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM
NCT02205047Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma
NCT04796454Pamiparib and Low Dose Temozolomide In Patients With Platinum Sensitive Biliary Tract Cancer
NCT03770468Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma
NCT03443856Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence
NCT03224104Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma
NCT03101475Synergism of Immunomodulation and Tumor Ablation
NCT04780464A 3 Arm Randomized Study on Health-related QoL of Elderly Patients With Advanced Soft Tissue Sarcoma
NCT04933942Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth Glioblastoma
NCT02172872"InDACtion" vs "3+7" Induction in AML
NCT04498767Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
NCT03859453Follow-up in Early and Locally Advanced Breast Cancer Patients
NCT03515993Follow-up in Gynecological Cancer Survivors
NCT02984410Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma
NCT02580994Pembrolizumab in Untreated Extensive SCLC
NCT01524926CREATE: Cross-tumoral Phase 2 With Crizotinib
NCT04402073Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma
NCT03517137Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study
NCT04218825REACH: Study to Determine the Aetiology of Chlormethine Gel Induced-skin Drug Reaction in Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL)
NCT00433589Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes
NCT01597414Elderly Metastatic Breast Cancer: Pertuzumab-Herceptin vs Pertuzumab-Herceptin-Metronomic Chemotherapy, Followed by T-DM1
NCT05259605Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification
NCT05209529Chemo-free BRCA-targeted Neoadjuvant Strategy
NCT03319316Combination of Durvalumab and Tremelimumab as Maintenance Treatment in Patients With Non Squamous and Squamous (NSCLC)
NCT03088059Biomarker-based Study in R/M SCCHN
NCT01652261Very Early FDG-PET/CT-response Adapted Therapy for Advanced Hodgkin Lymphoma (H11)
NCT03260712Pembrolizumab in Biliary Tract Cancer
NCT02808247Ph II Nintedanib vs. Ifosfamide in Soft Tissue Sarcoma
NCT01913652Ph II Cabazitaxel DD Liposarcoma
NCT03563040Study of Photopheresis in the Treatment of Erythrodermic MF and SS
NCT02799706Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer
NCT00047125Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor